Endocrine News Podcast

Our Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run. Let us know what you’d like to hear on the podcast by emailing us at [email protected]. Listen to Endocrine Feedback Loop, a new podcast series that is exclusively accessible to Endocrine Society members, to stay up-to-date on the latest medical literature published in our family of journals. A JOURNAL CLUB P ODCAST Listen to Endocrine Feedback

Read the full article here

Source: www.endocrine.org

Categories: Endocrinology, General Medicine News

Tweets with this article

Endocrine Society

2023 @Endocrine_News Podcast Rewind | Hit rewind on your favorite episodes! It's the perfect time to catch up with our Endocrine News podcasts from the past year. What topic resonated with you the most? Access our full archive: https://t.co/qX4vEeI2f5 https://t.co/xSjOA5BdFS

Transcriptomic profiling and machine learning reveal novel RNA signatures for enhanced molecular characterization of Hashimoto’s thyroiditis

Scientific Reports – Transcriptomic profiling and machine learning reveal novel RNA signatures for enhanced molecular characterization of Hashimoto’s thyroiditis

Johnson Thomas, MD, FACE January 4, 2025

Welcome! You are invited to join a webinar: Diabetes 101: The Science of Diabetes and the Law. After registering, you will receive a confirmation email about joining the webinar.

Join the American Diabetes Association and learn about the science of diabetes as it relates to legal issues. The presentation will provide an overview of…

ADA DiabetesPro January 4, 2025

Welcome! You are invited to join a meeting: Using Automated Insulin Delivery Devices in Diabetes Management. After registering, you will receive a confirmation email about joining the meeting.

This workshop–designed for primary care professionals, endocrinologists and other members of the diabetes care team–will offer participants an opportunity to learn from health care professionals…

ADA DiabetesPro January 3, 2025

Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial

All tested survodutide doses were tolerated, and dose-dependently reduced bodyweight.

The Lancet Diabetes & Endocrinology January 3, 2025

Abstracts | American Diabetes Association

Submit your abstract for consideration for the 84 th Scientific Sessions. The Scientific Sessions Meeting Planning Committee encourages submissions that are innovative, challenge current treatment…

ADA DiabetesPro January 3, 2025

Related Articles